(Q33806988)

29 July 2017

1 reference

title

Does subclinical rejection contribute to chronic rejection in renal transplant patients? (English)

1 reference

29 July 2017

Rush DN

1

1 reference

29 July 2017

Karpinski ME

2

1 reference

29 July 2017

Nickerson P

3

1 reference

29 July 2017

Dancea S

4

1 reference

29 July 2017

Birk P

5

1 reference

29 July 2017

Jeffery JR

6

1 reference

29 July 2017

1 December 1999

1 reference

29 July 2017

Clinical Transplantation

1 reference

29 July 2017

13

1 reference

29 July 2017

6

1 reference

29 July 2017

441-446

1 reference

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

29 July 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

Safety Aspects and Diagnostic Findings of Serial Renal Allograft Biopsies, Obtained by An Automatic Technique with a Midsize Needle

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

Cyclosporin and renal graft histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

Determinants of chronic renal allograft rejection in cyclosporine-treated recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

Lipid-lowering therapy in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

The value of needle renal allograft biopsy. I. A retrospective study of biopsies performed during putative rejection episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts. Predisposing factors, histology, immunohistochemistry, and relation to outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Banff criteria as predictors of outcome following acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Characteristics of early routine renal allograft biopsies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Histological findings in early routine biopsies of stable renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Histological outcome of acute cellular rejection in kidney transplantation after treatment with methylprednisolone

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Urine i-TXB2 in renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Histopathological findings in well-functioning, long-term renal allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

Interleukin 2 receptor expression on peripheral blood lymphocytes in association with renal allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.1999.130601.X

7 January 2021

10.1034/J.1399-0012.1999.130601.X

Identifiers

DOI

1 reference

29 July 2017

1 reference